220 related articles for article (PubMed ID: 15466384)
1. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology.
Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ
Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
3. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of d-type cyclins in podocytes in vitro and in vivo.
Petermann A; Hiromura K; Pippin J; Blonski M; Couser WG; Kopp J; Mundel P; Shankland SJ
Am J Pathol; 2004 Apr; 164(4):1417-24. PubMed ID: 15039229
[TBL] [Abstract][Full Text] [Related]
5. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo.
Brinkkoetter PT; Wu JS; Ohse T; Krofft RD; Schermer B; Benzing T; Pippin JW; Shankland SJ
Kidney Int; 2010 Apr; 77(8):690-9. PubMed ID: 20130526
[TBL] [Abstract][Full Text] [Related]
6. Podocyte expression of the CDK-inhibitor p57 during development and disease.
Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ
Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597
[TBL] [Abstract][Full Text] [Related]
7. The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development.
Mangold N; Pippin J; Unnersjoe-Jess D; Koehler S; Shankland S; Brähler S; Schermer B; Benzing T; Brinkkoetter PT; Hagmann H
Cells; 2021 Sep; 10(9):. PubMed ID: 34572114
[TBL] [Abstract][Full Text] [Related]
8. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.
Taniguchi Y; Pippin JW; Hagmann H; Krofft RD; Chang AM; Zhang J; Terada Y; Brinkkoetter P; Shankland SJ
Am J Physiol Renal Physiol; 2012 May; 302(9):F1161-71. PubMed ID: 22262481
[TBL] [Abstract][Full Text] [Related]
9. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
10. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism.
Liu W; Zhang Y; Hao J; Liu S; Liu Q; Zhao S; Shi Y; Duan H
J Cell Biochem; 2012 Oct; 113(10):3186-96. PubMed ID: 22614921
[TBL] [Abstract][Full Text] [Related]
11. Cyclin I and p35 determine the subcellular distribution of Cdk5.
Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT
Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740
[TBL] [Abstract][Full Text] [Related]
12. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells.
Brinkkoetter PT; Olivier P; Wu JS; Henderson S; Krofft RD; Pippin JW; Hockenbery D; Roberts JM; Shankland SJ
J Clin Invest; 2009 Oct; 119(10):3089-101. PubMed ID: 19729834
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
14. Podocytes, parietal cells, and glomerular pathology: the role of cell cycle proteins.
Nagata M; Tomari S; Kanemoto K; Usui J; Lemley KV
Pediatr Nephrol; 2003 Jan; 18(1):3-8. PubMed ID: 12488982
[TBL] [Abstract][Full Text] [Related]
15. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.
Mundel P; Reiser J; Zúñiga Mejía Borja A; Pavenstädt H; Davidson GR; Kriz W; Zeller R
Exp Cell Res; 1997 Oct; 236(1):248-58. PubMed ID: 9344605
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
17. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo.
Vaughan MR; Pippin JW; Griffin SV; Krofft R; Fleet M; Haseley L; Shankland SJ
Kidney Int; 2005 Jul; 68(1):133-44. PubMed ID: 15954902
[TBL] [Abstract][Full Text] [Related]
18. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
[TBL] [Abstract][Full Text] [Related]
19. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.
Barisoni L; Mokrzycki M; Sablay L; Nagata M; Yamase H; Mundel P
Kidney Int; 2000 Jul; 58(1):137-43. PubMed ID: 10886558
[TBL] [Abstract][Full Text] [Related]
20. Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation.
Zhu YS; Saito T; Asada A; Maekawa S; Hisanaga S
J Neurochem; 2005 Sep; 94(6):1535-45. PubMed ID: 15992363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
